Terms: = Lung cancer AND STAG2, RP11-517O1_1, 10735, ENSG00000101972, DKFZp781H1753, SA2, SA-2, FLJ25871, DKFZp686P168, bA517O1_1
120824 results:
1. Safety and efficacy of inebilizumab for the treatment of neuromyelitis optica spectrum disorder: end-of-study results from the open-label period of the N-MOmentum trial.
Cree BAC; Kim HJ; Weinshenker BG; Pittock SJ; Wingerchuk DM; Fujihara K; Paul F; Cutter GR; Marignier R; Green AJ; Aktas O; Hartung HP; She D; Rees W; Smith M; Cimbora D; Katz E; Bennett JL;
Lancet Neurol; 2024 Jun; 23(6):588-602. PubMed ID: 38760098
[TBL] [Abstract] [Full Text] [Related]
2. Arginine deprivation enriches lung cancer proteomes with cysteine by inducing arginine-to-cysteine substitutants.
Yang C; Pataskar A; Feng X; Montenegro Navarro J; Paniagua I; Jacobs JJL; Zaal EA; Berkers CR; Bleijerveld OB; Agami R
Mol Cell; 2024 May; 84(10):1904-1916.e7. PubMed ID: 38759626
[TBL] [Abstract] [Full Text] [Related]
3. Cysteine substitutants emerge in lung cancer proteomes during arginine restriction.
Hsu DJ; Tavazoie SF
Mol Cell; 2024 May; 84(10):1819-1821. PubMed ID: 38759621
[TBL] [Abstract] [Full Text] [Related]
4. Potential mechanism of Chai Gui Zexie Decoction for NSCLC treatment assessed using network pharmacology, bioinformatics, and molecular docking: An observational study.
Lin M; Zhao A; Chen B
Medicine (Baltimore); 2024 May; 103(20):e38204. PubMed ID: 38758858
[TBL] [Abstract] [Full Text] [Related]
5. PAI-1 mediates acquired resistance to MET-targeted therapy in non-small cell lung cancer.
Thu YM; Suzawa K; Tomida S; Ochi K; Tsudaka S; Takatsu F; Date K; Matsuda N; Iwata K; Nakata K; Shien K; Yamamoto H; Okazaki M; Sugimoto S; Toyooka S
PLoS One; 2024; 19(5):e0300644. PubMed ID: 38758826
[TBL] [Abstract] [Full Text] [Related]
6. Association of Remote Patient-Reported Outcomes and Step Counts With Hospitalization or Death Among Patients With Advanced cancer Undergoing Chemotherapy: Secondary Analysis of the PROStep Randomized Trial.
Manz CR; Schriver E; Ferrell WJ; Williamson J; Wakim J; Khan N; Kopinsky M; Balachandran M; Chen J; Patel MS; Takvorian SU; Shulman LN; Bekelman JE; Barnett IJ; Parikh RB
J Med Internet Res; 2024 May; 26():e51059. PubMed ID: 38758583
[TBL] [Abstract] [Full Text] [Related]
7. The later-line efficacy and safety of immune checkpoint inhibitors plus anlotinib in EGFR-mutant patients with EGFR-TKI-resistant NSCLC: a single-center retrospective study.
Yin X; Liu X; Ren F; Meng X
Cancer Immunol Immunother; 2024 May; 73(7):134. PubMed ID: 38758372
[TBL] [Abstract] [Full Text] [Related]
8. Identification and analysis of prognostic immune cell homeostasis characteristics in lung adenocarcinoma.
Sun Y; Ma Q; Chen Y; Liao D; Kong F
Clin Respir J; 2024 May; 18(5):e13755. PubMed ID: 38757752
[TBL] [Abstract] [Full Text] [Related]
9. Exploring Guolin Qigong (Mind-Body Exercise) for Improving cancer Related Fatigue in cancer Survivors: A Mixed Method Randomized Controlled Trial Protocol.
Low SLK; Ho GF; Liu B; Koh ES; Fei Y; Teo CS; Zhu X
Integr Cancer Ther; 2024; 23():15347354241252698. PubMed ID: 38757745
[TBL] [Abstract] [Full Text] [Related]
10. A combination of radiomic features, clinic characteristics, and serum tumor biomarkers to predict the possibility of the micropapillary/solid component of lung adenocarcinoma.
Xing X; Li L; Sun M; Zhu X; Feng Y
Ther Adv Respir Dis; 2024; 18():17534666241249168. PubMed ID: 38757628
[TBL] [Abstract] [Full Text] [Related]
11. Diagnostic yield using electromagnetic navigation bronchoscopy for peripheral pulmonary nodules <2 cm.
Chen JY; Yang H; Lin XD; Yang H; Wen J; Liu QW; Zhang LJ; Lin P; Fu JH; Leng CS; Yi R; Luo KJ
Ther Adv Respir Dis; 2024; 18():17534666241249150. PubMed ID: 38757612
[TBL] [Abstract] [Full Text] [Related]
12. Long non‑coding RNA lung cancer‑associated transcript 1 regulates ferroptosis via microRNA‑34a‑5p‑mediated GTP cyclohydrolase 1 downregulation in lung cancer cells.
Tai F; Zhai R; Ding K; Zhang Y; Yang H; Li H; Wang Q; Cao Z; Ge C; Fu H; Xiao F; Zheng X
Int J Oncol; 2024 Jun; 64(6):. PubMed ID: 38757341
[TBL] [Abstract] [Full Text] [Related]
13. Overexpression of wild-type HRAS drives non-alcoholic steatohepatitis to hepatocellular carcinoma in mice.
Ling C; Liu SS; Wang YY; Huo GT; Yang YW; Xu N; Wang H; Wu Y; Miao YF; Fu R; Zhao YW; Fan CF
Zool Res; 2024 May; 45(3):551-566. PubMed ID: 38757223
[TBL] [Abstract] [Full Text] [Related]
14. Case report: Sintilimab combined with anlotinib as neoadjuvant chemotherapy for metastatic bone tumor resection in patients with PSC.
Bao Z; Yu X; Zheng K; Zhai K; Cui H; Xu M
Front Immunol; 2024; 15():1372279. PubMed ID: 38756778
[TBL] [Abstract] [Full Text] [Related]
15. Clinic information, pathological, and imaging characteristics in 2 058 surgical patients with lung cancer from a single center.
Long B; Xiong Z; Liu S; Cheng Y; Li M; Liao W
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2024 Feb; 49(2):247-255. PubMed ID: 38755720
[TBL] [Abstract] [Full Text] [Related]
16. Associations between immune cell phenotypes and lung cancer subtypes: insights from mendelian randomization analysis.
Zheng JM; Lou CX; Huang YL; Song WT; Luo YC; Mo GY; Tan LY; Chen SW; Li BJ
BMC Pulm Med; 2024 May; 24(1):242. PubMed ID: 38755605
[TBL] [Abstract] [Full Text] [Related]
17. When to reinvite initially ineligible populations for targeted lung cancer screening?
Goodley P; Crosbie PAJ; Sperrin M; Merchant Z; Booton R; Balata H
BMJ Open Respir Res; 2024 May; 11(1):. PubMed ID: 38754907
[TBL] [Abstract] [Full Text] [Related]
18. Scoping review of exposure questionnaires and surveys in interstitial lung disease.
Barnes H; Elmrayed S; Barber CM; Feary J; Lee CT; Gandhi S; Peters CE; Salisbury ML; Johannson KA
BMJ Open Respir Res; 2024 May; 11(1):. PubMed ID: 38754906
[TBL] [Abstract] [Full Text] [Related]
19. Effect of a 3D-printed reconstruction automated matching system for selecting the size of a left double-lumen tube: a study protocol for a prospective randomised controlled trial.
Li L; Zhu Y; Yin F; Yu H; Wang H; Xu Y; Fei F; Liu W; Duan B; Wang F; Jia Y; Zhang H
BMJ Open; 2024 May; 14(5):e085503. PubMed ID: 38754878
[TBL] [Abstract] [Full Text] [Related]
20. Real-World Impact of Comprehensive Genomic Profiling on Biomarker Detection, Receipt of Therapy, and Clinical Outcomes in Advanced Non-Small Cell lung cancer.
Wallenta Law J; Bapat B; Sweetnam C; Mohammed H; McBratney A; Izano MA; Scannell Bryan M; Spencer S; Schroeder B; Hostin D; Simon GR; Berry AB
JCO Precis Oncol; 2024 May; 8():e2400075. PubMed ID: 38754057
[TBL] [Abstract] [Full Text] [Related]
[Next]
